• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

APOS:IT

94.30 ILs 4.00 4.07%

As of 07:49:29 ET on 07/22/2014.

Snapshot for Aposense Ltd (APOS)

Open: 98.30 Day's Range: 94.30 - 98.10 Volume: 10,000
Previous Close: 98.30 52wk Range: 75.50 - 168.40 1-Yr Rtn: -39.63%

Stock Chart for APOS

No chart data available.
  • APOS:IT 95.00
  • 1D
  • 1M
  • 1Y
98.30
Interactive APOS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for APOS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.5198
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 26.08
Shares Outstanding (M) 26.53
30 Day Average Volume 13,569
Price/Book (mrq) 0.4708
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for APOS

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for APOS

Aposense Limited is a clinical stage molecular imaging and drug development company. The Company has a pipeline of products based on its patented platform technology used for targeting apoptosis. Aposense Ltd targets multiple disease categories including oncology, cardiology, and neurology.

Miri Ben-AmiChief Executive OfficerDov FarkashChief Financial Officer
More Company Profile & Key Executives for APOS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil